Sava Infond D.O.O. Abbott Laboratories Transaction History
Sava Infond D.O.O.
- $524 Billion
- Q1 2025
A detailed history of Sava Infond D.O.O. transactions in Abbott Laboratories stock. As of the latest transaction made, Sava Infond D.O.O. holds 34,440 shares of ABT stock, worth $4.56 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
34,440
Previous 33,830
1.8%
Holding current value
$4.56 Million
Previous $3.83 Billion
19.39%
% of portfolio
0.87%
Previous 0.68%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,545Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.3 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.84 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.71 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...